Skip to main content
bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
2.660
+0.450 (20.36%)
At close: Apr 28, 2026, 4:00 PM EDT
2.590
-0.070 (-2.63%)
After-hours: Apr 28, 2026, 4:33 PM EDT

bioAffinity Technologies Revenue

In the year 2025, bioAffinity Technologies had annual revenue of $6.16M, down -34.18%. bioAffinity Technologies had revenue of $1.59M in the quarter ending December 31, 2025, a decrease of -27.85%.

Revenue (ttm)
$6.16M
Revenue Growth
-34.18%
P/S Ratio
1.61
Revenue / Employee
$108,105
Employees
57
Market Cap
11.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20256.16M-3.20M-34.18%
Dec 31, 20249.36M6.83M269.68%
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
Biodesix 88.50M
Exagen 66.58M
XWELL 29.21M
Precipio 24.05M
iSpecimen 1.93M
Mainz Biomed 537.08K
Revenue Rankings

BIAF News

More News